Risperidone for non-psychotic disorders in paediatric patients: Which child is to benefit?

摘要

The last two decades have witnessed a sharp rise in the prescription of second-generation antipsychotics to paedi-atric patients with non-psychotic disorders, most notably risperi'done. and aripiprazole. Data from the US have indicated a six-fold increase in prescriptions of antipsychotics from 1993 to 2002, with further increases in the years thereafter'. Between 2005 and 2009 as many as 31.1% of visits to child and adolescent psychiatrists included antipsy-chotic treatment, and 98.3% of prescriptions of an antipsy-chotic to children included a second-generation antipsychotic.